Robert B. Jenkins - Concepedia

Author

Robert B. Jenkins

Also Known As

C. Giannini, Christoffer Johansen, Huse, Jason, JENKINS, R, Jenkins, Robert, Jenkins, Robert B., John D Heiss, John Wiencke, R B Jenkins, R JENKINS

785

Publications

64.2K

Citations

116

H-Index

201

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Mayo Clinic in Florida WinnMed University of California, San Francisco

About

Robert B. Jenkins is an author at Mayo Clinic specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	74	170	21.7K
2	Health Sciences	26	37	3.3K
3	Engineering	6	6	810
4	Natural Sciences	6	6	493
5	Arts	1	1	27

Robert B. Jenkins

352

Publications

60.1K

Citations

111

H-Index

Page 1

	Year	Citations
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer Edward H. Romond, Edith A. Perez, John Bryant, New England Journal of Medicine	2005	5.3K
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, Journal of Clinical Oncology	2013	4K
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison, Journal of Clinical Oncology Tumor BiologyBreast Cancer GuidelineBreast OncologyClinical Oncology/collegeCancer Detection	2018	2.3K
Glioma Groups Based on 1p/19q,<i>IDH</i>, and<i>TERT</i>Promoter Mutations in Tumors Jeanette E. Eckel‐Passow, Daniel H. Lachance, Annette M Molinaro, New England Journal of Medicine	2015	1.9K
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks, Archives of Pathology & Laboratory Medicine	2013	1.8K
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer Lynn C. Hartmann, Daniel J. Schaid, John E. Woods, New England Journal of Medicine	1999	1.4K
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Journal of Thoracic Oncology	2013	1.3K
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 Gregory Cairncross, Meihua Wang, Edward Shaw, Journal of Clinical Oncology	2012	1.1K
cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” Daniel J. Brat, Kenneth Aldape, Howard Colman, Acta Neuropathologica Neuro-oncologyTumoral PathologyOncologyDiagnostic CriteriaMedicine	2018	846
Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas Justin S. Smith, Arie Perry, Thomas J. Borell, Journal of Clinical Oncology	2000	803

Page 1